Literature DB >> 32905781

YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.

Jiadong Liu1, Mingwei Gao1, Shuyang Xu2, Yaping Chen1, Kaixin Wu3, He Liu4, Jie Wang2, Xuejie Yang5, Junwei Wang2, Weiwei Liu6, Xichen Bao7, Jiekai Chen8.   

Abstract

N6-methyladenosine (m6A), the most abundant reversible modification on eukaryote messenger RNA, is recognized by a series of readers, including the YT521-B homology domain family (YTHDF) proteins, which are coupled to perform physiological functions. Here, we report that YTHDF2 and YTHDF3, but not YTHDF1, are required for reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). Mechanistically, we found that YTHDF3 recruits the PAN2-PAN3 deadenylase complex and conduces to reprogramming by promoting mRNA clearance of somatic genes, including Tead2 and Tgfb1, which parallels the activity of the YTHDF2-CCR4-NOT deadenylase complex. Ythdf2/3 deficiency represses mesenchymal-to-epithelial transition (MET) and chromatin silencing at loci containing the TEAD motif, contributing to decreased reprogramming efficiency. Moreover, RNA interference of Tgfb1 or the Hippo signaling effectors Yap1, Taz, and Tead2 rescues Ythdf2/3-defective reprogramming. Overall, YTHDF2/3 couples RNA deadenylation and regulation with the clearance of somatic genes and provides insights into iPSC reprogramming at the posttranscriptional level.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo signaling pathway; RNA degradation; YTHDFs; reprogramming

Mesh:

Substances:

Year:  2020        PMID: 32905781     DOI: 10.1016/j.celrep.2020.108120

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

Review 1.  Processing body (P-body) and its mediators in cancer.

Authors:  Bernard Nsengimana; Faiz Ali Khan; Ebenezeri Erasto Ngowi; Xuefeng Zhou; Yu Jin; Yuting Jia; Wenqiang Wei; Shaoping Ji
Journal:  Mol Cell Biochem       Date:  2022-01-28       Impact factor: 3.396

2.  The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity.

Authors:  Jiadong Liu; Mingwei Gao; Jiangping He; Kaixin Wu; Siyuan Lin; Lingmei Jin; Yaping Chen; He Liu; Junjie Shi; Xiwei Wang; Lei Chang; Yingying Lin; Yu-Li Zhao; Xiaofei Zhang; Man Zhang; Guan-Zheng Luo; Guangming Wu; Duanqing Pei; Jie Wang; Xichen Bao; Jiekai Chen
Journal:  Nature       Date:  2021-03-03       Impact factor: 49.962

3.  ALKBH5 regulates somatic cell reprogramming in a phase-specific manner.

Authors:  Sherif Khodeer; Arne Klungland; John Arne Dahl
Journal:  J Cell Sci       Date:  2022-06-10       Impact factor: 5.235

Review 4.  Emerging Perspectives of RNA N 6-methyladenosine (m6A) Modification on Immunity and Autoimmune Diseases.

Authors:  Lipeng Tang; Xingyan Wei; Tong Li; Yi Chen; Zhenhua Dai; Chuanjian Lu; Guangjuan Zheng
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

5.  Sin3a drives mesenchymal-to-epithelial transition through cooperating with Tet1 in somatic cell reprogramming.

Authors:  Jiabao Feng; Fugui Zhu; Dan Ye; Qingquan Zhang; Xudong Guo; Changsheng Du; Jiuhong Kang
Journal:  Stem Cell Res Ther       Date:  2022-01-24       Impact factor: 6.832

Review 6.  Evolution of the Neocortex Through RNA-Binding Proteins and Post-transcriptional Regulation.

Authors:  Iva Salamon; Mladen-Roko Rasin
Journal:  Front Neurosci       Date:  2022-01-10       Impact factor: 4.677

Review 7.  N6-Methyladenosine RNA Modification: A Potential Regulator of Stem Cell Proliferation and Differentiation.

Authors:  Bo Wei; Meiyu Zeng; Jing Yang; Shuainan Li; Jiantao Zhang; Nan Ding; Zhisheng Jiang
Journal:  Front Cell Dev Biol       Date:  2022-04-04

Review 8.  The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms.

Authors:  Qibo Huang; Jie Mo; Zhibin Liao; Xiaoping Chen; Bixiang Zhang
Journal:  Cell Death Dis       Date:  2022-10-07       Impact factor: 9.685

Review 9.  Ribosome dynamics and mRNA turnover, a complex relationship under constant cellular scrutiny.

Authors:  Christelle Morris; David Cluet; Emiliano P Ricci
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-05       Impact factor: 9.957

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.